Does Sleep Foundation or AASM Support Cannabis for Insomnia? 

Patients researching medical cannabis often ask whether respected organisations, such as the Sleep Foundation or the American Academy of Sleep Medicine (AASM), endorse its use. At present, the cannabis and sleep foundation or AASM positions remain cautious, reflecting the need for more conclusive research before formal approval is given. 

While both groups recognise the growing interest in cannabis for insomnia, they emphasise evidence-based practice and continue to recommend established therapies first. Their approach highlights the importance of professional guidelines in shaping treatment choices. 

Current Medical Positions on Cannabis for Sleep 

Although neither the Sleep Foundation nor AASM directly supports cannabis as a first-line therapy, their guidance provides insight into how cannabis is viewed in clinical settings. Below are the key points. 

AASM Position 

The AASM has taken a stronger stance, warning that existing evidence is limited and that potential side effects must be carefully weighed. Its medical positions highlight that traditional therapies, such as cognitive behavioural therapy for insomnia (CBT-I), should remain the preferred option. 

Shared Message 

Together, the Sleep Foundation and AASM underline the importance of further clinical trials before cannabis can be widely accepted for insomnia  treatment. 

Ultimately, the cannabis and sleep foundation or AASM perspective demonstrates that while interest is high, evidence must catch up with patient demand. 

Visit providers like LeafEase for personalised consultations that help patients balance current guidelines with emerging treatment options. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Insomnia.